Sponsor:
Canadian Forces Health Services Centre Ottawa
Code:
NCT05367531
Conditions
Overdose Antidote
Bleeding
Allergic Reaction
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
Interventions
Autoinjector
Standard Injector
Prefilled
Brief summary:
Conditions
Overdose Antidote
Bleeding
Allergic Reaction
Study ID
NCT05367531
Start date
Apr 30, 2022
Status verified date
Feb, 2023
Completion date
Jan 1, 2025
Anticipated
Primary completion date
Dec 1, 2024
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
Enrollment
30 participants
Anticipated
Intervention Model
Single group
Primary purpose
Other
Arms
experimental: Injection Scenario
Interventions
Autoinjector
Standard Injector
Prefilled
Primary outcome measure
Central contacts
Locations
Canadian Forces
Recruiting
Ottawa, Ontario, Canada, K1K 0T2
Contacts
Sponsor
Canadian Forces Health Services Centre Ottawa
Last update posted
Feb 8, 2023
Last verified
Feb, 2023
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Canadian Forces Health Services Centre Ottawa on 2023-02-08.